Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
about
Krüppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer.Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.[Expression of Acetaldehyde Dehydrogenase in Gefitinib-resistant Human Lung Adenocarcinoma HCC-827/GR Cells].
P2860
Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liver X receptors agonist GW39 ...... by inhibiting NF-κB in vitro.
@en
Liver X receptors agonist GW39 ...... by inhibiting NF-κB in vitro.
@nl
type
label
Liver X receptors agonist GW39 ...... by inhibiting NF-κB in vitro.
@en
Liver X receptors agonist GW39 ...... by inhibiting NF-κB in vitro.
@nl
prefLabel
Liver X receptors agonist GW39 ...... by inhibiting NF-κB in vitro.
@en
Liver X receptors agonist GW39 ...... by inhibiting NF-κB in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Liver X receptors agonist GW39 ...... by inhibiting NF-κB in vitro.
@en
P2093
Haixia Cao
Huanhuan Sha
Jialan Zang
Jianzhong Wu
Jifeng Feng
Leilei Zhou
P2860
P304
15802-15814
P356
10.18632/ONCOTARGET.15007
P407
P577
2017-02-02T00:00:00Z